Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.80 |
| ▸ | MEN1 | O00255 | 3/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.80 |
| ▸ | MAPT | P10636 | 2/20 | 0.80 |
| ▸ | RECQL | P46063 | 2/20 | 0.80 |
| ▸ | USP2 | O75604 | 1/20 | 0.80 |
| ▸ | PLEC | Q15149 | 1/20 | 0.80 |
| ▸ | DRD2 | P14416 | 5/20 | 0.74 |
| ▸ | DRD3 | P35462 | 5/20 | 0.74 |
| ▸ | HTR2B | P41595 | 5/20 | 0.74 |
| ▸ | HTR6 | P50406 | 5/20 | 0.74 |
| ▸ | HTR2A | P28223 | 5/20 | 0.74 |
| ▸ | HTR1A | P08908 | 4/20 | 0.74 |
| ▸ | DRD4 | P21917 | 4/20 | 0.74 |
| ▸ | DRD5 | P21918 | 4/20 | 0.74 |
| ▸ | HTR1D | P28221 | 4/20 | 0.74 |
| ▸ | HTR1E | P28566 | 4/20 | 0.74 |
| ▸ | HTR7 | P34969 | 4/20 | 0.74 |
| ▸ | HRH1 | P35367 | 4/20 | 0.74 |
| ▸ | HTR5A | P47898 | 4/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29473364 | 1.00 | KDM4E (0.80) | KDM4EMEN1KMT2AMAPTRECQL | |
| SCHEMBL11533855 | 1.00 | KDM4E (0.80) | KDM4EMEN1KMT2AMAPTRECQL | |
| SCHEMBL1162252 | 1.00 | KDM4E (0.80) | KDM4EMEN1KMT2AMAPTRECQL | |
| SCHEMBL12951376 | 1.00 | KDM4E (0.80) | KDM4EMEN1KMT2AMAPTRECQL | |
| SCHEMBL183687 | 1.00 | KDM4E (0.80) | KDM4EMEN1KMT2AMAPTRECQL | |
| Water SCHEMBL11245600 | 0.99 | KDM4E (0.79) | KDM4EMEN1KMT2AMAPTRECQL | |
| Ammonia Solution, Strong SCHEMBL5792359 | 0.99 | KDM4E (0.79) | KDM4EMEN1KMT2AMAPTRECQL | |
| Ammonia Solution, Strong SCHEMBL26970704 | 0.99 | KDM4E (0.79) | KDM4EMEN1KMT2AMAPTRECQL | |
| Hydrochloric Acid SCHEMBL31443171 | 0.99 | KDM4E (0.79) | KDM4EMEN1KMT2AMAPTRECQL | |
| Acetamide SCHEMBL29094036 | 0.96 | KDM4E (0.74) | KDM4EMEN1KMT2AMAPTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4674894-A2 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2026-01-07 | — | — | EP | claimed |
| EP-4663688-A2 | CROSSLINKERS | Hemoteq AG (DE) | 2025-12-17 | — | — | EP | claimed |
| EP-4642780-A2 | PROCESS FOR SYNTHESIZING 2-BROMOLYSERGIC ACID DIETHYLAMIDE VIA CONTROLLED HYDROLYSIS OF BROMOCRIPTINE | Ceruvia Lifesciences LLC (US) | 2025-11-05 | — | — | EP | claimed |
| CN-118956995-B | Method for producing lysergic acid by fermentation | 扬州联澳生物医药有限公司 | 2025-04-22 | — | — | CN | claimed |
| US-20240287057-A1 | PROCESS FOR SYNTHESIZING 2-BROMOLYSERGIC ACID DIETHYLAMIDE VIA CONTROLLED HYDROLYSIS OF BROMOCRIPTINE | CERUVIA LIFESCIENCES LLC (US) | 2024-08-29 | — | — | US | claimed |
| US-20240228479-A1 | PROCESS FOR SYNTHESIZING 2-BROMOLYSERGIC ACID DIETHYLAMIDE VIA CONTROLLED BROMINATION OF LYSERGIC ACID | CERUVIA LIFESCIENCES LLC (US) | 2024-07-11 | — | — | US | claimed |
| WO-2024145604-A2 | PROCESS FOR SYNTHESIZING 2-BROMOLYSERGIC ACID DIETHYLAMIDE VIA CONTROLLED HYDROLYSIS OF BROMOCRIPTINE | CERUVIA LIFESCIENCES LLC (US) | 2024-07-04 | — | — | WO | claimed |
| WO-2024145546-A1 | PROCESS FOR SYNTHESIZING 2-BROMOLYSERGIC ACID DIETHYLAMIDE VIA CONTROLLED BROMINATION OF LYSERGIC ACID | CERUVIA LIFESCIENCES LLC (US) | 2024-07-04 | — | — | WO | claimed |
| CN-116024107-B | Engineering bacterium for producing lysergic acid, construction method and application thereof | 中国科学院青岛生物能源与过程研究所 | 2023-10-03 | — | — | CN | claimed |
| CN-116024107-A | Engineering bacterium for producing lysergic acid, construction method and application thereof | 中国科学院青岛生物能源与过程研究所 | 2023-04-28 | — | — | CN | claimed |
| CN-1956985-A | Process for the manufacture of lysergic acid | IVAX PHARMACEUTICALS SRO (CZ) | 2007-05-02 | — | — | CN | claimed |
| EP-1718644-A1 | PROCESS FOR THE MANUFACTURE OF LYSERGIC ACID | IVAX Pharmaceuticals s.r.o. (CZ) | 2006-11-08 | — | — | EP | claimed |
| WO-2005082902-A1 | PROCESS FOR THE MANUFACTURE OF LYSERGIC ACID | IVAX PHARMACEUTICALS S.R.O. (CZ) | 2005-09-09 | — | — | WO | claimed |
| EP-0072286-B2 | ORGANIC AMIDE COMPOUNDS DERIVED FROM NITROGENOUS LIPIDS | FIDIA S.p.A. (IT) | 1992-12-09 | — | — | EP | claimed |
| EP-0205068-B1 | LYSERGIC-ACID AMIDES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM | ARZNEIMITTELWERK DRESDEN GmbH (DE) | 1992-01-02 | — | — | EP | claimed |
| EP-0095092-B1 | PROCESS FOR THE PREPARATION OF LYSERGIC ACID ESTERS | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-12-30 | — | — | EP | claimed |
| EP-0072286-B1 | ORGANIC AMIDE COMPOUNDS DERIVED FROM NITROGENOUS LIPIDS | FIDIA S.p.A. (IT) | 1986-10-29 | — | — | EP | claimed |
| US-4524208-A | Process for the preparation of lysergic acid esters | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-06-18 | — | — | US | claimed |
| EP-0095092-A2 | Process for the preparation of lysergic acid esters | SCHERING AKTIENGESELLSCHAFT (DE) | 1983-11-30 | — | — | EP | claimed |
| EP-0072286-A1 | Organic amide compounds derived from nitrogenous lipids | FIDIA S.p.A. (IT) | 1983-02-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240287057-A1 | PROCESS FOR SYNTHESIZING 2-BROMOLYSERGIC ACID DIETHYLAMIDE VIA CONTROLLED HYDROLYSIS OF BROMOCRIPTINE | LIPA, CEL, LIPE | KDM4E 944/4885MEN1 2600/4885KMT2A 101/4885 |
| US-20240228479-A1 | PROCESS FOR SYNTHESIZING 2-BROMOLYSERGIC ACID DIETHYLAMIDE VIA CONTROLLED BROMINATION OF LYSERGIC ACID | LIPA, NAAA, BRS3 | KDM4E 1037/4885MEN1 3530/4885KMT2A 65/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.